Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2004 Feb 23;147(1):41–48. doi: 10.1016/0042-6822(85)90225-9

Difference in sensitivity to interferon among mouse hepatitis viruses with high and low virulence for mice

Fumihiro Taguchi 1,1, Stuart G Siddell 1
PMCID: PMC7130510  PMID: 2998070

Abstract

Mouse hepatitis viruses (MHV) of different virulence for mice were studied with respect to interferon (IFN) sensitivity. The growth of low-virulent MHV-S and intermediately virulent MHV-JHM was significantly suppressed in IFN-treated L cells compared with untreated cells. However, a comparable suppression of the growth of highly virulent MHV-2 was not observed in IFN-treated cells. This differential effect of IFN treatment could also be demonstrated at the level of viral mRNA and viral proteins. In cells infected with MHV-S or MHV-JHM the amount of viral mRNAs was remarkably reduced by IFN treatment. Also the levels of the major intracellular viral proteins, in particular the E, protein, were affected by IFN treatment. Similar effects could not be demonstrated in MHV-2-infected cells. These results suggest that during MHV-S or MHV-JHM infection IFN treatment suppresses virus replication at several stages. The significance of these results is discussed in terms of the pathogenecity of these viruses.

References

  1. Bang F.B., Warwick A. Vol. 46. 1960. Mouse macrophages as host cells for the mouse hepatitis virus and the genetic basis of their susceptibility; pp. 1065–1075. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Garlinghouse L.E., Smith A.L., Holford T. The biological relationship of mouse hepatitis virus (MHV) strains and interferon: In vitro induction and sensitivities. Arch. Virol. 1984;82:19–29. doi: 10.1007/BF01309365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hirano N., Murakami T., Taguchi F., Fujiwara K., Matumoto M. Comparison of mouse hepatitis virus strains for pathogenicity in weanling mice infected by various routes. Arch. Virol. 1981;70:69–73. doi: 10.1007/BF01320795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hirano N., Takenaka S., Fujiwara K. Pathogenicity of mouse hepatitis virus for mice depending upon host age and route of infection. Japan J. Exp. Med. 1975;45:287–294. [PubMed] [Google Scholar]
  5. Kumanishi T. Brain tumors induced with Rous sarcoma virus, Schmidt-Ruppin strain. I. Induction of brain tumors in adult mice with Rous chicken sarcoma cells. Japan J. Exp. Med. 1967;37:461–474. [PubMed] [Google Scholar]
  6. Lai M.M.C., Patton C.D., Stohlman S.A. Replication of mouse hepatitis virus: Negative-stranded RNA and replicative form RNA are of genome length. J. Virol. 1982;44:487–492. doi: 10.1128/jvi.44.2.487-492.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Maniatis T., Frisch E.F., Sambrook J. Cold Spring Harbor, New York; New York: 1982. (Molecular Cloning—A Laboratory Manual). [Google Scholar]
  8. Mogensen S.C. Role of macrophages in natural resistance to virus infections. Microbiol. Rev. 1979;43:1–26. doi: 10.1128/mr.43.1.1-26.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Pelham H.R.B., Jackson R.J. An efficient mRNA dependent translation system from reticulocyte lysates. Eur. J. Biochem. 1976;67:247–256. doi: 10.1111/j.1432-1033.1976.tb10656.x. [DOI] [PubMed] [Google Scholar]
  10. Piazza M. Thomas; Springfield, Ill: 1969. Experimental Viral Hepatitis. [Google Scholar]
  11. Rottier P., Spaan W.J.M., Horzinek M.C., van der Zeijst B.A.M. Translation of three mouse hepatitis virus strain A59 subgenomic RNAs in Xenopus laevis oocytes. J. Virol. 1981;38:20–26. doi: 10.1128/jvi.38.1.20-26.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Siddell S. Coronavirus JHM: Coding assignments of subgenomic mRNAs. J. Gen. Virol. 1983;64:113–125. doi: 10.1099/0022-1317-64-1-113. [DOI] [PubMed] [Google Scholar]
  13. Siddell S., Wege H., Barthel A., ter Meulen V. Coronavirus JHM: Cell-free synthesis of structural protein p60. J. Virol. 1980;33:10–17. doi: 10.1128/jvi.33.1.10-17.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Siddell S., Wege H., Barthel A., ter Meulen V. Coronavirus JHM: Intracellular protein synthesis. J. Gen Virol. 1981;53:145–155. doi: 10.1099/0022-1317-53-1-145. [DOI] [PubMed] [Google Scholar]
  15. Siddell S., Wege H., ter Meulen V. The biology of coronaviruses. J. Gen. Virol. 1983;64:761–776. doi: 10.1099/0022-1317-64-4-761. [DOI] [PubMed] [Google Scholar]
  16. Skinner M.A., Siddell S. Coronavirus JHM: Nucleotide sequence of the mRNA that encodes nucleocapsid protein. Nucleic Acids Res. 1983;15:5045–5054. doi: 10.1093/nar/11.15.5045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Spaan W., Delius H., Skinner M., Armstrong J., Rottier P., Smeekens S., van der Zeijst B.A.M., Siddell S. Coronavirus mRNA synthesis involves fusion of non-contiguous sequence. EMBO J. 1983;2:1839–1844. doi: 10.1002/j.1460-2075.1983.tb01667.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stohlman S.A., Frelinger J.A., Weiner L.P. Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. II. Adherent cell-mediated protection. J. Immunol. 1981;124:1733–1739. [PubMed] [Google Scholar]
  19. Sturman L.S., Holmes K.V. The molecular biology of coronaviruses. Adv. Virus Res. 1983;28:35–112. doi: 10.1016/S0065-3527(08)60721-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Taguchi F., Aiuchi M., Fujiwara K. Age-dependent response of mice to a mouse hepatitis virus, MHV-S. Japan J. Exp. Med. 1977;47:109–115. [PubMed] [Google Scholar]
  21. Taguchi F., Hirano N., Kiuchi Y., Fujiwara K. Difference in response to mouse hepatitis virus among susceptible mouse strains. Japan J. Microbiol. 1976;20:293–302. doi: 10.1111/j.1348-0421.1976.tb00991.x. [DOI] [PubMed] [Google Scholar]
  22. Taguchi F., Kawamura S., Fujiwara K. Replication of mouse hepatitis viruses with high and low virulence in cultured hepatocytes. Infect. Immun. 1983;39:955–959. doi: 10.1128/iai.39.2.955-959.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Taguchi F., Siddell S., Wege H., ter Meulen V. Characterization of a variant virus selected in rat brain after infection by coronavirus mouse hepatitis virus JHM. J. Virol. 1985;54:429–435. doi: 10.1128/jvi.54.2.429-435.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Taguchi F., Yamada A., Fujiwara K. Factors involved in the age-dependent resistance of mice infected with low-virulence mouse hepatitis virus. Arch. Virol. 1979;62:333–340. doi: 10.1007/BF01318107. [DOI] [PubMed] [Google Scholar]
  25. Taguchi F., Yamada A., Fujiwara K. Resistance to highly virulent mouse hepatitis virus acquired by mice after low-virulence infection: Enhanced antiviral activity of macrophages. Infect. Immun. 1980;29:42–49. doi: 10.1128/iai.29.1.42-49.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Taguchi F., Yamaguchi R., Makino S., Fujiwara K. Correlation between growth potential of mouse hepatitis viruses in macrophages and their virulence for mice. Infect. Immun. 1981;34:1059–1061. doi: 10.1128/iai.34.3.1059-1061.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Virelezier J.L., Allison A.C. Correlation of persistent mouse hepatitis virus (MHV-3) infection with its effect on mouse macrophage culture. Arch. Virol. 1976;50:279–285. doi: 10.1007/BF01317953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Virelezier J.L., Allison A.C., De Maeyer E. Production by mixed lymphocyte cultures of a type II interferon able to protect macrophages against virus infection. Infect. Immun. 1977;17:282–285. doi: 10.1128/iai.17.2.282-285.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Virelezier J.L., Gresser I. Role of interferon in the pathogenesis of viral diseases of mice as demonstrated by the use of anti-interferon serum. V. Protective role in mouse hepatitis virus type 3 infection of susceptible and resistant strains of mice. J. Immunol. 1978;120:1616–1619. [PubMed] [Google Scholar]
  30. Wege H., Siddell S., ter Meulen V. The biology and pathogenesis of coronaviruses. Curr. Topics Microbiol. Immunol. 1982;99:165–200. doi: 10.1007/978-3-642-68528-6_5. [DOI] [PubMed] [Google Scholar]
  31. Weiser N.Y., Bang F.B. Blocking of in vitro and in vivo susceptibility to mouse hepatitis virus. J. Exp. Med. 1977;146:1467–1472. doi: 10.1084/jem.146.5.1467. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Virology are provided here courtesy of Elsevier

RESOURCES